Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
作者信息
MacIntyre D E, Bushfield M, MacMillan L J, Moffat K J, Murdoch F A, Thomson A, Rossi A G, McNicol A
出版信息
Agents Actions Suppl. 1986;20:45-62.
PMID:3028106
Abstract
摘要
相似文献
1
Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
Agents Actions Suppl. 1986;20:45-62.
2
Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Adv Prostaglandin Thromboxane Res. 1980;6:389-93.
3
Role of thromboxane A2.
Adv Exp Med Biol. 1985;192:293-308. doi: 10.1007/978-1-4615-9442-0_21.
4
Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent.
Adv Prostaglandin Thromboxane Leukot Res. 1983;11:429-33.
5
Control and interrelation of aggregation and secretion; the roles of Ca2+, diacylglycerol and thromboxane with particular reference to ADP stimulation.
Adv Exp Med Biol. 1985;192:145-62. doi: 10.1007/978-1-4615-9442-0_11.
6
Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
Adv Prostaglandin Thromboxane Res. 1980;6:417-25.
7
Characterization of thromboxane receptors in human platelets.
Adv Exp Med Biol. 1985;192:67-81. doi: 10.1007/978-1-4615-9442-0_6.
8
Normal mechanisms of platelet function.
Clin Haematol. 1983 Feb;12(1):107-51.
9
Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
Thromb Haemost. 1985 Oct 30;54(3):612-6.
10
Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins.
Thromb Res. 1977 Dec;11(6):705-13. doi: 10.1016/0049-3848(77)90099-8.
引用本文的文献
1
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective.
Biochem Pharmacol. 2020 Oct;180:114147. doi: 10.1016/j.bcp.2020.114147. Epub 2020 Jul 10.
Zotero 插件